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Magnetic nanoassemblies possess in most cases more efficient properties than 
magnetically-independent nanoparticles, due to their increased magnetic 
properties and stronger magnetic responses. As an example, the use of magnetic 
nanoassemblies instead of single nanoparticles can short the handling time of 
hyperthermia treatment because magnetic interactions can enhance their heating 
power. 1,2   . 
Consequently, gaining control on the assembly of magnetic nanoparticles is a 
milestone that scientist should aim at. Interestingly, nature has provided an 
outstanding model to follow: biogenic magnetite of magnetic bacteria 3-6. These 
organisms efficiently assemble single magnetic nanocrystals which are utilizd to 
passively align the bacteria with the geomagnetic field for orientation and 
navigation. Biogenic magnetite exhibits fascinating magnetic properties that could 
be suitable for biotechnological7-10 however they are recalcitrant to large-scale 
production and they are unprecedented in their use for human oral administration. 
An alternative for the assembly of magnetic nanomaterials might be to replicate 
natural magnetic bacteria. Towards this end, efforts have been made to create 
structurally-mimetic magnetic bacteria by synthesizing magnetosomes in cells, 
either directed by the magA gene or by transfecting cells to express the magA 
protein11,12. .We report a different approach. Whilst our focus was inspired by 
magnetotactic bacteria, we attempted to mimic their functionality rather than their 
structure. We used the non-magnetic probiotic bacteria Lactobacillus fermentum or 
Lactobacillus fermentum and Bifidobacteria breve as bioplatforms to densely 
arrange maghemite nanoparticles on their external surfaces, thus obtaining what 
we call artificial magnetic bacteria. These probiotic bacteria, in contrast to native 
magnetic bacteria, are well known to have a positive effect on  the maintenance of 
human health since they constitute an important part of natural microbiota.  
 In the artificial magnetic bacteria, dipole–dipole interactions occur between 
nanoparticles due to their close proximity, so that maghemite nanoparticles 
spontaneously assemble with the application of an external magnetic field and 
induce the probiotic bacteria to behave as magnets at room temperature. The use 
of an external magnetic fi eld is in fact one of the most common routes to achieve 






obtained are often limited to short-range chains which are usually prone to 
uncontrolled aggregation, with subsequent negative effects, for instance for 
biomedical applications. Our system of artificial magnetic bacteria overcomes 
these limitations: the presence of the bacteria as a platform facilitates the fixation 
of chains and the whole magnetic system remains in solution.   
 
Results and Discussion  
Our strategy to graft maghemite nanoparticles on Gram positive probiotics 
involves a two-step procedure in which, after halting the proliferation of probiotic 
bacteria, nude maghemite nanoparticles are deposited onto the bacteria biofi lm.  
The adsorption of magnetic nanoparticles takes place within the biofi lm, which is 
an extra-bacterial conglomeration of products, composed mainly of 
polysaccharides, that surrounds the bacterial wall. In fact, when the bacterial biofi 
lm was removed following a standard protocol, no assembly of particles 
surrounding the probiotic bacteria was observed, but a random aggregation at the 
extra-bacterial space was found (Figure S1). Moreover, as the biofilms are 
polyanionic due to the presence of either uronic acids or ketal-linked pyruvates, 
the nude particles are required to be positively charged18,19  Thus, while positive 
maghemite nanoparticles attach onto the external bacteria surface, the negative 
ones show no affinity for deposition (Figure S2).  We have succeeded in the 
preparation of a batch of artificial magnetic bacteria with iron contents ranging 
from 0.1 to 25 mg of iron per gram of bacteria by controlling the ratio of the 
amount of attached maghemite nanoparticles in regards to the quantity of bacteria.  
Figure 1 shows typical transmission electron microscopy (TEM) images of samples 








Figure 1. Typical TEM micrographs of thin epoxy resin sections of Lactobacillus fermentum loaded 
with different iron amounts. Iron contents per g of bacteria were 0.1 (left) and 25 mg (right). Scale 
bars are 200 nm. 
The bacteria, labeled with maghemite nanoparticles, are easily redispersed in 
water forming a red-dark solution. The sample with the highest iron loading (25 
mg of iron/g bacteria) was deeply examined, both by TEM and magnetic 
measurements. Large accumulations of nanoparticles were seen on the external 
bacterial surface in a “plum pudding” formation, where the magnetic nanoparticles 
are positively-charged “plums” onto a “pudding” constituted by the bacterial biofi 
lm (Figure 2). Figure 2 b shows a typical high-resolution (HR)-TEM image of an 
agglomerate of nanoparticles surrounding the bacteria wall. They were well-
defined, showing spherical-like topologies with heterogeneous size (average size 
of 10.0 nm, σ = 1.2 after measuring 100 nanoparticles). The corresponding 
electron diffraction pattern (Figure 2d) and measured d-spacing (Figure 2 e) were 
indexed according to the maghemite structure20 X-ray powder diffraction (XRD) 
measurements of the magnetic colloid (Figure S3) also showed typical patterns for 
maghemite. Based on the calculations with the Debye–Scherrer’s formula the mean 
maghemite nanoparticle size was 10.7 nm, accordingly with the sizes measured by 
TEM.   
 
Figure 2. a) A non-contrasted TEM image of the sample containing 25 mg of iron/g of bacteria. It is 
noticeable that the bacterium is perfectly visible without the use of contrast, with the electron-
dense maghemite nanoparticles themselves providing contrast. b) A zone at higher magnifi cation 






surrounding the bacterial wall (marked with an arrow in the fi gure). d) An electronic diffraction 
pattern of a representative particle. e) HRTEM image of a single maghemite particle with labeled d-
spacing values. 
The wide shell of particles surrounding the bacteria wall was visualized using high 
annular dark field-scanning transmission electron microscopy (HAADF-STEM;  
Figure 3a). To confirm the presence of the iron nanoparticles around the bacteria, 
energy dispersive X-ray spectroscopy (EDX) experiments were performed, which 
showed the juxtaposition of iron (in red) and the bacterial matrix. The spatial 
distribution of iron (Figure 3b), which was barely detectable inside the bacteria or 
in the inter-bacterial region, indicates clearly that the iron nanoparticles were 
incorporated into the external bacterial region, embedded in the biofi lm.   
 
 
Figure 3.    a) HAADF-STEM micrograph of a thin epoxy resin section showing the presence of 
particles at the external surface or artificial magnetic bacteria. b) EDX compositional maps of iron 
collected over the whole HAADF-STEM image in (a). 
 
While individual maghemite nanoparticles of this size range (10 nm) are 
superparamagnetic at room temperature and do not show persistent 
magnetization21,22 , the artificial magnetic bacteria of highest iron content (25 mg 
of iron/g of bacteria) become magnets at room temperature. This was seen 
without any assistance of a microscope (Figure 4). This magnetic behavior is due 
to the assembly process of nano particles caused by magnetic dipole–dipole 
interaction between them onto single bacteria. In fact, the blocking temperature 
(TB) of these maghemite nanoparticles shifts from 160 K to practically room 








bacteria with the highest iron content (Figure  4e,f). It should be noted that the 
broadening of the TB peak of the artificial magnetic bacteria is due to the existence 
of magnetic assemblies of different length and shapes, which make difficult the 
exact determination of TB, which can be estimated close to room temperature 
(Figure 4 e). Therefore, whereas the transition from the superparamagnetic to the 
ferromagnetic phase occurs at 160 K22   in the maghemite nanoparticles (10 nm), 
this transition moves to room temperature once they are assembled onto the 
probiotic bacteria. It means more than 100 K higher. In fact, magnetization data at 
300 K showed hysteresis with coercivity of 50 Oe (Figure 4 f), although the 
assemblies do not show a single-domain behavior (Mrs/Ms < 0.5) as typically 
found in magnetotactic bacteria.  
 
 
Figure 4.    a) Dispersion of maghemite nanoparticles (average size of 10 nm) in aqueous media. b) 
The application of a magnet to the dispersion produces no effect. c) Dispersion of the highest iron-
containing artifi cial magnetic bacteria in aqueous media. d) Separation of the artifi cial magnetic 
bacteria by application of a magnet. e) Field-cooled (FC) and zero-fi eld-cooled (ZFC) curves of 
lyophilized powders of maghemite nanoparticles (black) and artificial magnetic bacteria (red). f) 
Hysteresis curves at 300 K of lyophilized powders of maghemita nanoparticles (black) and artificial 
magnetic bacteria (Red). Inset: zooming of the region at low magnetic fields. 
 
Therefore, the artificial magnetic bacteria behave as magnets at room temperature, 






structures bear no similarity. While natural magnetic bacteria usually contain 
internal chains of a few magnetic nanocrystals, our artificial magnetic bacteria are 
enriched with thousands of magnetic nanoparticles deposited at their external 
surface.  
The artificial magnetic bacteria showed the ability to swim (Figure S4) and be 
guided towards a target when exposed to a directional magnetic fi eld. The 
artificial magnetic bacteria were labeled with fluorescent green SYTO9 (Figure 5) 
to visualize the response to an external magnetic field. This fluorophore is 
commonly used for the labeling of live bacteria, which, incidentally, demonstrated 
that the bacteria remain alive after grafting the magnetic nanoparticles.  As it is 
shown in Figure 5, on placing a permanent magnet (0.3 T) to a drop of aqueous 
solution of the artificial magnetic bacteria deposited in polylysine glass, magnetic 
nanoassembly occurred. The artificial magnetic bacteria became directionally 
arranged following the magnetic fi eld lines. Note that the application of the same 
external magnet to the maghemite nanoparticles in the absence of bacteria 
produces no effect (Figure 3 b). This fact points out the crucial role of the bacteria 
as platforms to assembly the magnetic nanoparticles and therefore inducing the 
artificial bacteria to behave as magnets at room temperature. The similarities and 
differences between the biogenic and our biometic magnetic bacteria should be 
highlighted here. Firstly, nature chose magnetite crystals of the appropriate size, 
usually larger than 50 nm3,4 .This is a wise “decision” of nature, since smaller 
crystals would not contribute efficiently to the bacteria magnetic moment. 
However, here we demonstrate that we can produce, from superparamagnetic 
small maghemite nanoparticles (10 nm in size), magnetic bacteria that present a 
collective ferromagnetic phase at room temperature, although a single domain 












Figure 5.    Arrangement on polylysine glass of the artificial magnetic bacteria labeled with the 
green SYTO9 after applying an external magnetic field. Inset: A single chain fragment is magnified 
to highlight the magnetic order of these artificial magnetic bacteria. Every fluorescent spot 
corresponds to an artificial magnetic bacterium. 
 
On the other hand, in our biomimetic magnetic bacteria, a 3D cylindrical shell 
architecture is built from maghemite nanoparticles that implies a highly complex 
process of assembly. Interestingly, this assembly (Figure 4) resembles the 
filamentous structure of twisted strands found in some magnetotactic bacteria, 23   
with the difference that while in our artificial magnetic bacteria every brick is by 
itself a magnetic bacterium, in biogenic magnetic bacteria, the bricks are 
magnetosomes. From a crude magnetic point of view, artificial magnetic bacteria 
differ from most native ones. Thus, whereas some native magnetic bacteria are 
able to align themselves with the Earth magnetic field (50 µT), the minimal 
magnetic fi eld required for arranging the artificial bacteria was 30 mT. However, it 
should be noted that, the functional magnetosome chains usually aggregate when 
extracted from native bacteria. This aggregation worsens their magnetic 
properties and therefore their biomedical applications. In fact, a decrease in the 
coercivity and reduced remanence is observed in extracted magnetosomes if 
compared with the whole magnetotactic bacteria 24. Nevertheless, and in order to 
advance in the pursuit of mimicking their functionality as closely as possible, we 
wanted to take advantage of their features. The artificial magnetic bacteria 
resulted to exhibit some magnetic behaviors that reminded those of the native 
ones: the possibility to be magnetically ordered (Figure  5 ) and the ability to swim 






But, at the same time, our synthetic system presented some advantages with 
respect to the native one.  Firstly, it provided fl exibility for monitoring the iron 
loading per bacterium.  
Interestingly, in all the assayed iron content range, most bacteria remain alive and 
in fact, the viability does not fall below 1·108 CFU (colony forming units), which is 
in the range of the accepted values for labeling bacteria as a probiotic (see 
Experimental Section). Secondly, the probiotic are not unprecedented in human 
administration since their well-known healthy effect, in particular in the 
promotion of the immune system activity, the defense against infections and 
because their anti-infl ammatory properties25,26  . 
Furthermore, certain probiotics have emerged as biological vectors with tumor 
specificity and therapy activity27  as due to their anaerobic nature of probiotic, they 
are known to specifically localize at the hypoxic regions of solid tumors 28,29 .  
 
Conclusion 
We have developed a simple and powerful methodology to create magnetic 
bacteria from superparamagnetic nanoparticles and probiotics. The artificial 
magnetic bacteria resulted to exhibit some magnetic behaviors that reminded the 
key features of native ones: they are alive and become magnetically ordered at 
room temperature, although the magnetic fi eld required is sensible higher than 
the geomagnetic one. However, this synthetic system presented some advantages 
with respect to the native one: flexibility for monitoring the iron loading per 
bacterium and good viability.  
In the basis on their magnetic properties, these artificial magnetic bacteria, as it 
occurs for native ones, have a broad window of biomedical applications, i.e., MRI, 
hyperthermia, biosensors, etc.7–10. However, it must be emphasized that while 
native magnetic bacteria are unprecedented in their administration to humans, our 
artifi cial magnetic bacteria are made of probiotic bacteria, widely incorporated in 
food since they confer health benefi ts for humankind. In addition, our procedure 
involves mild chemical conditions and may be easily adapted to large-scale 
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